 |
|
UT School of Public Health researchers discover significant efficacy of travelers' diarrhea vaccine
June 12, 2008Researchers at The University of Texas School of Public Health have found that patients given a travelers' diarrhea vaccine were significantly less likely to suffer from clinically significant diarrhea than those who received placebo, according to a study published in this week's edition of the Lancet. The patch-based vaccine is part of the Phase 2 study in conjunction with the Iomai Corporation.
The study, which followed 170 healthy travelers ages 18-64 to Mexico and Guatemala, found that of the 59 individuals who received the novel vaccine, only three suffered from moderate or severe diarrhea, while roughly two dozen of the 111 who received a placebo suffered from moderate or severe diarrhea. Only one of the 59 volunteers in the vaccine group reported severe diarrhea, compared with 12 in the placebo group.
"These results suggest that the Iomai patch has the potential to fundamentally change the way we approach prevention of this disease, an ailment against which we now have very few weapons," said Herbert L. DuPont, M.D., professor and director of the Center for Infectious Diseases at The University of Texas School of Public Health and the principal investigator of the trial. "If these results are replicated, the Iomai vaccine will have the potential to not only mitigate a disease that sickens millions each year but also keep some patients from going on to develop the chronic symptoms of irritable bowel syndrome."
The Trek Study was done in collaboration with UT Houston, the Johns Hopkins Bloomberg School of Public Health and other institutions. Each volunteer received either two doses of the vaccine patch or a placebo, 2 to 3 weeks apart, with the last dose administered a week before travel. Travelers kept detailed diaries and received in-country checkups. The study was designed to evaluate the safety of the vaccine and the incidence of enterotoxigenic E. coli (ETEC) bacteria - the most common cause of travelers' diarrhea. No vaccine-related serious side effects were reported.
Of the few vaccinated patients who became sick, the diarrhea lasted only half a day on average, while those in the placebo group endured two days of illness and more than twice as many loose stools. Although not statistically significant, the frequency of new-onset irritable bowel syndrome, a long-term consequence of travelers' diarrhea, was three times greater in placebo than vaccine recipients.
This year, approximately 55 million international travelers will visit countries where bacteria that cause travelers' diarrhea are endemic, particularly Africa, Asia and Latin America, and about 20 million of those will develop travelers' diarrhea.
In addition to the acute symptoms of travelers' diarrhea, which include severe diarrhea, abdominal cramps and dehydration, patients who suffer a bout of travelers' diarrhea are also at higher risk of developing irritable bowel syndrome, a chronic condition characterized by pain, bloating, diarrhea or constipation. Diarrheal disease also exacts a significant toll on children in the developing world, where diarrhea linked to enterotoxigenic E. sickens 210 million children each year, killing an estimated 380,000 annually.
"Bacterial diarrheal disease is a significant medical problem both for children and travelers, and our technology represents both an advance in vaccine delivery and a breakthrough in the field of infectious disease," said Gregory Glenn, M.D., Iomai's chief scientific officer. "We look forward to targeting both the significant travelers' market and developing the vaccine for the children in the developing world who still suffer serious morbidity and mortality from this disease."
Iomai plans to initiate a Phase 3 program for the needle-free vaccine patch vaccine in 2009. If approved, the Iomai vaccine would be the first vaccine for travelers' diarrhea available in the United States.
University of Texas Health Science Center at Houston
The Trek Study was done in collaboration with UT Houston, the Johns Hopkins Bloomberg School of Public Health and other institutions. Each volunteer received either two doses of the vaccine patch or a placebo, 2 to 3 weeks apart, with the last dose administered a week before travel. Travelers kept detailed diaries and received in-country checkups. The study was designed to evaluate the safety of the vaccine and the incidence of enterotoxigenic E. coli (ETEC) bacteria - the most common cause of travelers' diarrhea. No vaccine-related serious side effects were reported.
Of the few vaccinated patients who became sick, the diarrhea lasted only half a day on average, while those in the placebo group endured two days of illness and more than twice as many loose stools. Although not statistically significant, the frequency of new-onset irritable bowel syndrome, a long-term consequence of travelers' diarrhea, was three times greater in placebo than vaccine recipients.
This year, approximately 55 million international travelers will visit countries where bacteria that cause travelers' diarrhea are endemic, particularly Africa, Asia and Latin America, and about 20 million of those will develop travelers' diarrhea.
In addition to the acute symptoms of travelers' diarrhea, which include severe diarrhea, abdominal cramps and dehydration, patients who suffer a bout of travelers' diarrhea are also at higher risk of developing irritable bowel syndrome, a chronic condition characterized by pain, bloating, diarrhea or constipation. Diarrheal disease also exacts a significant toll on children in the developing world, where diarrhea linked to enterotoxigenic E. sickens 210 million children each year, killing an estimated 380,000 annually.
"Bacterial diarrheal disease is a significant medical problem both for children and travelers, and our technology represents both an advance in vaccine delivery and a breakthrough in the field of infectious disease," said Gregory Glenn, M.D., Iomai's chief scientific officer. "We look forward to targeting both the significant travelers' market and developing the vaccine for the children in the developing world who still suffer serious morbidity and mortality from this disease."
Iomai plans to initiate a Phase 3 program for the needle-free vaccine patch vaccine in 2009. If approved, the Iomai vaccine would be the first vaccine for travelers' diarrhea available in the United States.
University of Texas Health Science Center at Houston
Diarrhea Current Events and Diarrhea News RSSCommentary warns of unexpected consequences of proton pump inhibitor use in reflux disease
Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases.
Deadly stomach infection rising in community settings, Mayo Clinic study finds
Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile is on the rise in outpatient settings.
Probiotic Found to Be Effective Treatment for Colitis In Mice
The probiotic, Bacillus polyfermenticus, can help mice recover from colitis, a new study has found.
Eating right, not supplements, is best at keeping your good bacteria healthy, dietitian says
Healthy eating, not supplements, is the best way to keep the good bacteria in your gut healthy, says a dietitian and researcher.
The bowels of infection
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology.
3-day course of antibiotics may be sufficient following tonsillectomy
Children who receive a three-day course of antibiotics following tonsillectomy rather than a seven-day course appear to have no differences in pain or how quickly they return to a normal diet and activity level.
Countries slow to use lifesaving diarrhea treatments for children
Despite evidence that low-cost diarrhea treatments such as lower osmolarity oral rehydration salts (ORS) and zinc supplements could drastically reduce the number of deaths among children, little progress has been made in implementing these life-saving techniques.
Frozen assets: NIAID researchers turn to unique resource for clues to norovirus evolution
A search through decades-old frozen infant stool samples has yielded rich dividends for scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimer's
People taking one of several drugs commonly prescribed to treat Alzheimer's disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications.
Peer pressure builds more latrines than financial assistance
Government subsidies persuade some people to change habits, but social shame works even better, suggests a recent study of efforts to reduce elevated childhood death and disease rates blamed on the microbial pathogens that cause diarrhea in rural India.
More Diarrhea Current Events and Diarrhea News Articles
 |
Kirkland Signiture Anti-Diarrheal - 400 Caplets by Kirkland Controls the symptoms of diarrhea, including Travelers' Diarrhea. Every Kirkland Signature product is guaranteed to meet or exceed the quality standards of the leading national brands. If you are not completely satisfied, your money will be refunded. Directions: Drink plenty of clear fluids to help prevent dehydration, which may accompany diarrhea. Find right dose on chart. If possible, use weight to dose; otherwise, use age. Adults and children 12 years and over: 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets a day. Children 9-11 years (60-95 lbs.): 1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 3caplets a day. Children 6-8 years (48-59 lbs.): 1 caplet after the first... |
 |
Imodium A-D Anti-Diarrhea, 72-Count Caplets by Imodium Take control with Imodium A-D Anti-Diarrhea Caplets. Imodium works with your body to get it back to normal when you have diarrhea. |
 |
Diarrhea (Telford Press Series) by Michael Gracey (Editor) This book helps bring the busy practitioner up to date with recent developments in research on diarrhea that has taken place over the past 10 years. The causes of diarrhea are very diverse and include infections, allergies, chronic inflammatory diseases, tumors and inborn errors of intestinal digestion and transport. The global importance of diarrheal deaths and illnessess, as well as the rapid technical advances that have occurred in this field, have generated a vast amount of literature that is not easily accessible to most practicing doctors. This single volume brings this literature together in a logical, concise and clear manner that puts diarrhea and its management into a clinical perspective. Practicing physicians, pediatricians, internists and senior students will find this book... |
 |
Ask Me About My Explosive Diarrhea Funny Womens Babydoll tee Shirt in 6 Colors Small thru XL by 99 Volts |
 |
Digestive Advantage IBS - Irritable Bowel Syndrome, Capsules, 96-Count by Digestive Advantage Digestive Advantage IBS is for the dietary management of Irritable Bowel Syndrome. It is formulated to manage the full range of irritable bowel syndrome symptoms including diarrhea, constipation, bloating, cramps, and urgency. This unique formulation helps Digestive Advantage IBS normalize the gut and support a normal diet. Digestive Advantage IBS is a caplet taken once per day and provides 24-hour relief to Irritable Bowel Syndrome (IBS) symptoms. The power behind Digestive Advantage IBS is a patented blend of lactobacillus cultures with an amino acid which facillitates digestion of dairy, fruits, meats, and carbohydrates. Digestive Advantage IBS is unique because it helps to relieve both ends of the IBS spectrum: Diarrhea and Constipation. |
 |
Lambert Kay Pet Pectillin Diarrhea Medication for Dogs, Cats, and Birds 4 fl.oz. by Lambert Kay diarrhea, pectillin, medication, dog, cat, bird Pet Pectillin Diarrhea Medication is an aid in the treatment of diarrhea. Improvement is noticeable in two to three days. Pet Pectillin Diarrhea Medication contains pectin and kaolin. Pectin provides a protective coating to irritated gastrointestinal membranes. It is also a detoxifying agent against bacterial toxins which cause inflammation of the gastrointestinal membranes and diarrhea. Kaolin, an adsorbent, increases the bulk and slows down the passage of feces. It also absorbs and promotes the excretion of toxins within the gastrointestinal tract. dog diarrhea medicine |
 |
Isomil DF Soy Formula For Diarrhea, Ready to Feed, Case of Six Bottles- each 32 Fluid Ounces by Isomil For firming loose, watery stools, Isomil DF is for the dietary management of diarrhea in infants older than 6 months and toddlers. Isomil DF should not be fed to infants or toddlers with constipation. |
 |
Live Fast Diarrhea by The Vandals As evidenced by the title, the Vandals haven't grown up at all on their 5th album, Live Fast Diarrhea. Neither their humor nor their musical skills have developed past the junior high level, as they still pound out three-chord punk at a fast clip, shouting out vulgarities. Features the tracks 'Let The Bad Times Roll', 'And Now We Dance' and more. A Nitro Records. |
 |
Washington Homeopathic Products Combination Remedy for Diarrhea (#10) by Washington Homeopathic Products About Washington Homeopathics (WHP) Washington Homeopathic Pharmacy (WHP) is the world leader in homeopathic and began in 1873 in Washington, DC. In 1991, Joe and Linda Lillard bought the pharmacy. In less than 20 years Washington Homeopathic Products has grown from a storefront pharmacy to one that is now serving over 65,000 customers in more than twenty countries. Today, WHP is the oldest full line homeopathic manufacturer in the nation offering a selection of over 1700 homeopathic medicines. They strive to make just about every product they offer. All plant materials used to manufacture homeopathic medicine must be organically grown. Over 50 species of plants used to process remedies are grown on the Lillards West Virginia farm. Sourcing local botanical materials... |
 |
Diarrhea Betty Blowtorch (Primary Contributor) |
| © 2009 BrightSurf.com |